A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-201 Clinical Trial

NCT03183804 · clinicaltrials.gov ↗

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Foot Ulcer

Interventions

BIOLOGICAL: ALLO-ASC-DFU
OTHER: Standard therapy

Sponsor

Anterogen Co., Ltd.